Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 54
Filter
Add more filters

Publication year range
1.
J Gastroenterol Hepatol ; 38(12): 2053-2060, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37644698

ABSTRACT

BACKGROUND AND AIM: Early-onset colorectal cancer (CRC) is a growing global health concern, especially in the Asia-Pacific region. However, comprehensive research on this topic from the region is lacking. Our study aims to investigate trends in early-onset CRC in Asia over 10 years, filling this research gap. METHODS: This study utilized data from the Global Burden of Disease Study 2019 to assess temporal trends in early-onset CRC in the Asia-Pacific. The analysis included estimating annual frequencies and age-standardized rates (ASRs) of early-onset CRC incidence, death, and disability-adjusted life-years (DALYs) by gender. RESULTS: The incidence of early-onset CRC significantly increased in both regions with higher increase and in the Western Pacific region. Notable increases were observed among males in the Western Pacific and females in Southeast Asia (SEA). Mortality rates remained stable in the Western Pacific but increased by 10.6% in SEA, especially among females. DALYs due to CRC also increased significantly in SEA, with a greater rise among females. The Western Pacific had the highest CRC incidence, and in SEA, the mortality rate was higher in females than males. CONCLUSIONS: Our study reveals a substantial increase in early-onset CRC in the Asia-Pacific underscoring the urgency for effective interventions. Thus, a comprehensive approach comprising controlled risk reduction, health promotion to heightened disease awareness, and implementation of effective screening strategies should be executed timely to mitigate the burden of early-onset CRC.


Subject(s)
Colorectal Neoplasms , Global Health , Male , Humans , Female , Incidence , Asia/epidemiology , Asia, Southeastern/epidemiology , Colorectal Neoplasms/epidemiology , Colorectal Neoplasms/diagnosis , Quality-Adjusted Life Years
2.
Dig Dis Sci ; 66(3): 861-865, 2021 03.
Article in English | MEDLINE | ID: mdl-32248392

ABSTRACT

OBJECTIVES: Laparoscopic cholecystectomy (LC) following acute gallstone cholangitis reduces the recurrence of biliary symptoms; however, the timing of LC has not been determined yet. The aim of our study was to evaluate the impact of performing LC during admission on the 30-day readmission rate. METHODS: We conducted a retrospective cohort study of acute gallstone cholangitis patients who underwent endoscopic clearance (EC) of the bile duct through endoscopic retrograde cholangiopancreatography between April 2013 and May 2018. Patients were classified into two groups: EC only group and EC followed by LC during admission (EC + LC) group. The primary outcome was the 30-day readmission rate. RESULTS: A total of 95 patients with acute cholangitis were included in the analysis. Of these patients, 35 patients (36.8%) underwent LC during admission. The 30-day readmission rate was significantly lower in the EC + LC group compared to the EC group (2.9% vs. 26.7%, P 0.003). In a multivariate regression analysis, patients who underwent LC during admission had 90% lower odds of readmission within 30 days compared to patients who did not (OR 0.1, 95% CI (0.01-0.9), P 0.04). CONCLUSIONS: Performing laparoscopic cholecystectomy during admission for acute gallstone cholangitis patients following endoscopic clearance of the bile duct significantly reduced the 30-day readmission rate without affecting the length of stay.


Subject(s)
Cholangiopancreatography, Endoscopic Retrograde/statistics & numerical data , Cholangitis/surgery , Cholecystectomy, Laparoscopic/statistics & numerical data , Gallstones/surgery , Patient Readmission/statistics & numerical data , Time Factors , Acute Disease , Aged , Cholangiopancreatography, Endoscopic Retrograde/methods , Cholecystectomy, Laparoscopic/methods , Combined Modality Therapy , Female , Humans , Male , Recurrence , Regression Analysis , Retrospective Studies , Treatment Outcome
3.
Curr Opin Gastroenterol ; 36(6): 538-546, 2020 11.
Article in English | MEDLINE | ID: mdl-32925176

ABSTRACT

PURPOSE OF REVIEW: Gastric vascular abnormalities are a well known cause of gastrointestinal bleeding. Due to their recurrent bleeding tendency and potential to cause life-threatening blood loss, gastric vascular abnormalities can result in significant morbidity and cost. RECENT FINDINGS: There have been novel advances in medical and endoscopic management of gastric vascular lesions. New data suggest that endoscopic band ligation and ablation may be comparable, or even superior, to argon plasma coagulation (APC) for management of gastric antral vascular ectasia (GAVE). A creative, highly sensitive and specific computer-assisted tool has been developed to facilitate reading video capsule endoscopies for the detection of angiodysplasias, paving the way for artificial intelligence incorporation in vascular lesions diagnostics. Over-the-scope clipping is a relatively new technology that shows promising results in controlling bleeding from Dieulafoy's lesions. SUMMARY: In this article, we will broadly review the management of the most prevalent gastric vascular lesions, focusing on the most recent areas of research.


Subject(s)
Artificial Intelligence , Gastric Antral Vascular Ectasia , Argon Plasma Coagulation , Gastric Antral Vascular Ectasia/diagnosis , Gastric Antral Vascular Ectasia/surgery , Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Hemorrhage/etiology , Gastrointestinal Hemorrhage/therapy , Humans , Treatment Outcome
4.
Am J Gastroenterol ; 114(8): 1322-1342, 2019 08.
Article in English | MEDLINE | ID: mdl-31205135

ABSTRACT

INTRODUCTION: Detailed recommendations and guidelines for acute pancreatitis (AP) management currently exist. However, quality indicators (QIs) are required to measure performance in health care. The goal of the Acute Pancreatitis Task Force on Quality was to formally develop QIs for the management of patients with known or suspected AP using a modified version of the RAND/UCLA Appropriateness Methodology. METHODS: A multidisciplinary expert panel composed of physicians (gastroenterologists, hospitalists, and surgeons) who are acknowledged leaders in their specialties and who represent geographic and practice setting diversity was convened. A literature review was conducted, and a list of proposed QIs was developed. In 3 rounds, panelists reviewed literature, modified QIs, and rated them on the basis of scientific evidence, bias, interpretability, validity, necessity, and proposed performance targets. RESULTS: Supporting literature and a list of 71 proposed QIs across 10 AP domains (Diagnosis, Etiology, Initial Assessment and Risk Stratification, etc.) were sent to the expert panel to review and independently rate in round 1 (95% of panelists participated). Based on a round 2 face-to-face discussion of QIs (75% participation), 41 QIs were classified as valid. During round 3 (90% participation), panelists rated the 41 valid QIs for necessity and proposed performance thresholds. The final classification determined that 40 QIs were both valid and necessary. DISCUSSION: Hospitals and providers managing patients with known or suspected AP should ensure that patients receive high-quality care and desired outcomes according to current evidence-based best practices. This physician-led initiative formally developed 40 QIs and performance threshold targets for AP management. Validated QIs provide a dependable quantitative framework for health systems to monitor the quality of care provided to patients with known or suspected AP.


Subject(s)
Pancreatitis/diagnosis , Pancreatitis/therapy , Quality Indicators, Health Care , Advisory Committees , Analgesics/therapeutic use , Anti-Bacterial Agents/therapeutic use , Cholangiopancreatography, Endoscopic Retrograde , Cholecystectomy , Consensus , Delphi Technique , Disease Management , Drainage , Fluid Therapy , Gallstones/complications , Gallstones/diagnosis , Gallstones/therapy , Gastroenterologists , Hospitalists , Humans , Nutritional Support , Pain Management , Pancreatitis/etiology , Pancreatitis, Acute Necrotizing/diagnosis , Pancreatitis, Acute Necrotizing/etiology , Pancreatitis, Acute Necrotizing/therapy , Reproducibility of Results , Risk Assessment , Surgeons
5.
Curr Opin Gastroenterol ; 35(6): 517-523, 2019 11.
Article in English | MEDLINE | ID: mdl-31592967

ABSTRACT

PURPOSE OF REVIEW: Upper gastrointestinal bleeding (UGIB) is a common and life-threatening condition in the United States and worldwide. RECENT FINDINGS: There have been several exciting recent advances in the endoscopic management of UGIB. One such advance is the recent approval of Hemospray by US Food and Drug Administration in May 2018. Another one is the emerging role of video capsule endoscopy as a triage and localization tool for UGIB patients. Finally, the development of new reversal agents for antithrombotic medications is an important advance in the management of life-threatening upper gastrointestinal bleed. SUMMARY: In this article, we will broadly review the management of nonvariceal UGIB, focusing primarily on the data addressing these new advances.


Subject(s)
Capsule Endoscopy/methods , Gastrointestinal Hemorrhage/pathology , Gastrointestinal Hemorrhage/therapy , Hemostasis, Endoscopic/methods , Capsule Endoscopy/trends , Endoscopy, Gastrointestinal/methods , Female , Forecasting , Gastrointestinal Hemorrhage/diagnosis , Humans , Male , Minerals/pharmacology , Patient Safety , Prognosis , Risk Assessment , Treatment Outcome , United States , United States Food and Drug Administration
6.
Dig Dis Sci ; 64(9): 2514-2526, 2019 09.
Article in English | MEDLINE | ID: mdl-31152333

ABSTRACT

BACKGROUND: Acute pancreatitis (AP) is a common and expensive condition. Improving quality of care in AP is vital to minimizing cost and improving patient outcomes. However, there has been little work accomplished toward developing and validating explicit quality indicators (QIs) in AP. AIMS: To define quality of care in patients with AP by developing explicit QIs using standardized techniques. METHODS: We used the UCLA/RAND Delphi panel approach to combine a comprehensive literature review with the collective judgment of experts to identify a defined set of process measures for AP. RESULTS: We produced 164 candidate QIs after a comprehensive literature review. After Delphi review, 75 had a median rating ≥ 7. We excluded 11 QIs where the disagreement index exceeded 1.0 and combined indicators overlapping in content to produce a final list of 22 QIs. Overall, 8 QIs related to diagnosis, prevention, or determination of etiology, 2 QIs focused on determination of severity, 3 QIs captured fluid resuscitation, 2 QIs measured nutrition, 1 QI use of antibiotics, and 6 QIs captured endoscopic or surgical management. CONCLUSIONS: We have developed 22 QIs spanning the spectrum of AP management including diagnosis, risk stratification, and pharmacological and endoscopic therapy. These QIs will facilitate future quality improvement by practitioners and organizations who treat patients with AP and further identify areas that are amenable to improvement to enhance patient care. We anticipate that this QI set will represent the first step in determining a framework for demonstrating value in the care of patients with AP.


Subject(s)
Pancreatitis/diagnosis , Pancreatitis/therapy , Quality Improvement , Quality Indicators, Health Care , Anti-Bacterial Agents/therapeutic use , Delphi Technique , Endoscopy, Digestive System/standards , Fluid Therapy/standards , Humans , Nutrition Assessment , Pancreatitis/etiology , Pancreatitis/prevention & control , Patient Acuity , Resuscitation/standards , Review Literature as Topic , Risk Assessment
7.
Clin Gastroenterol Hepatol ; 16(6): 918-926.e1, 2018 06.
Article in English | MEDLINE | ID: mdl-29074446

ABSTRACT

BACKGROUND & AIMS: It is not clear whether digital single-operator cholangioscopy (D-SOC) with electrohydraulic and laser lithotripsy is effective in removal of difficult biliary stones. We investigated the safety and efficacy of D-SOC with electrohydraulic and laser lithotripsy in an international, multicenter study of patients with difficult biliary stones. METHODS: We performed a retrospective analysis of 407 patients (60.4% female; mean age, 64.2 years) who underwent D-SOC for difficult biliary stones at 22 tertiary centers in the United States, United Kingdom, or Korea from February 2015 through December 2016; 306 patients underwent electrohydraulic lithotripsy and 101 (24.8%) underwent laser lithotripsy. Univariate and multivariable analyses were performed to identify factors associated with technical failure and the need for more than 1 D-SOC electrohydraulic or laser lithotripsy session to clear the bile duct. RESULTS: The mean procedure time was longer in the electrohydraulic lithotripsy group (73.9 minutes) than in the laser lithotripsy group (49.9 minutes; P < .001). Ducts were completely cleared (technical success) in 97.3% of patients (96.7% of patients with electrohydraulic lithotripsy vs 99% patients with laser lithotripsy; P = .31). Ducts were cleared in a single session in 77.4% of patients (74.5% by electrohydraulic lithotripsy and 86.1% by laser lithotripsy; P = .20). Electrohydraulic or laser lithotripsy failed in 11 patients (2.7%); 8 patients were treated by surgery. Adverse events occurred in 3.7% patients and the stone was incompletely removed from 6.6% of patients. On multivariable analysis, difficult anatomy or cannulation (duodenal diverticula or altered anatomy) correlated with technical failure (odds ratio, 5.18; 95% confidence interval, 1.26-21.2; P = .02). Procedure time increased odds of more than 1 session of D-SOC electrohydraulic or laser lithotripsy (odds ratio, 1.02; 95% confidence interval, 1.01-1.03; P < .001). CONCLUSIONS: In a multicenter, international, retrospective analysis, we found D-SOC with electrohydraulic or laser lithotripsy to be effective and safe in more than 95% of patients with difficult biliary stones. Fewer than 5% of patients require additional treatment with surgery and/or extracorporeal shockwave lithotripsy to clear the duct.


Subject(s)
Endoscopy, Gastrointestinal/adverse effects , Endoscopy, Gastrointestinal/methods , Gallstones/therapy , Lithotripsy/adverse effects , Lithotripsy/methods , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Republic of Korea , Retrospective Studies , Treatment Outcome , United Kingdom , United States , Young Adult
8.
Curr Opin Gastroenterol ; 34(6): 436-443, 2018 11.
Article in English | MEDLINE | ID: mdl-30299288

ABSTRACT

PURPOSE OF REVIEW: To review new advances in managing nonvariceal upper gastrointestinal hemorrhage. RECENT FINDINGS: Implementation of various scoring systems in combination with video capsule endoscopy assists in stratifying and managing nonvariceal upper gastrointestinal bleeding. New techniques such as thermocoagulation and hemoclips are useful to treat bleeding. SUMMARY: The advancement of methods and procedures in managing nonvariceal upper gastrointestinal bleeding has decreased mortality of patients presenting with this type of hemorrhage. In this chapter, we will be discussing various scores to stratify nonvariceal upper gastrointestinal bleeding and techniques to stop bleeding.


Subject(s)
Gastrointestinal Hemorrhage/therapy , Capsule Endoscopy/methods , Electrocoagulation/methods , Endoscopy, Gastrointestinal/methods , Gastrointestinal Hemorrhage/diagnosis , Hemostasis, Endoscopic/methods , Humans , Resuscitation/methods , Risk Assessment/methods , Triage/methods
9.
Pancreatology ; 18(3): 269-274, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29500114

ABSTRACT

OBJECTIVES: The aim of this study was to evaluate the impact of smoking on quality of life in patients with chronic pancreatitis. METHODS: This is a cross-sectional study of chronic pancreatitis patients followed at a single institution comparing smokers with non-smokers. The primary outcome was quality of life and secondary outcomes included demographics, drug and alcohol use, anxiety and depression, pain level, nutritional status, and metabolic factors. RESULTS: 48 smokers and 45 non-smokers participated in this study. Smokers had a worse overall quality of life and higher rates of opioid addiction and depression than non-smokers. Smokers also had less racial diversity, lower education levels, and higher amounts of narcotic use than non-smokers. Furthermore, smokers had a lower BMI and a higher proportional use of pancreatic enzyme replacement therapy. Smoking was found to be independently associated with worse quality of life on multivariable regression. CONCLUSIONS: The worse overall quality of life and higher rates of depression and anxiety create cause for concern in chronic pancreatitis patients who smoke. Smoking cessation should be an important target in chronic pancreatitis patients. Multicenter, multiethnic studies are needed to further elucidate this relationship.


Subject(s)
Pancreatitis, Chronic/psychology , Quality of Life , Smokers/psychology , Adult , Aged , Anxiety/psychology , Cohort Studies , Cross-Sectional Studies , Depression/complications , Depression/psychology , Educational Status , Enzyme Replacement Therapy , Female , Humans , Male , Middle Aged , Narcotics , Nutritional Status , Prospective Studies , Socioeconomic Factors
10.
Curr Opin Gastroenterol ; 33(6): 461-466, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28832360

ABSTRACT

PURPOSE OF REVIEW: To review new advances in gastric interventional endoscopy. RECENT FINDINGS: Implementation of gastric endoscopy as a therapeutic option in obesity, gastric cancer, and gastroparesis. SUMMARY: Less invasive new gastric endoscopic procedures can potentially replace currently offered laparoscopic approaches in many fields. In this article, we will review the use of endoscopic sleeve gastroplasty as a weight loss procedure, endoscopic submucosal dissection in treatment of early gastric cancer, and gastric per-oral endoscopic myotomy in treatment of refractory gastroparesis. These procedures can increase access to bariatric weigh loss procedures, provide an organ-saving curative option for early gastric cancer, and offer a new modality to improve refractory gastroparesis.


Subject(s)
Endoscopic Mucosal Resection/methods , Gastroplasty/methods , Pyloromyotomy/methods , Gastroparesis/surgery , Humans , Obesity/surgery , Stomach Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL